Stockholm, Feb 28, 2026, 08:07 (CET) — Market closed.
- Denmark’s OMXC25 fell about 4.7% on the week, weighed by Novo Nordisk’s sharp slide after an obesity-drug trial setback. 1
- The OMX Nordic 40 ended the week down roughly 2.2%, even after a firmer Friday close. 2
- Traders now look to March 6 U.S. jobs data and mid-March central bank decisions for the next shift in rate bets. 3
Denmark’s blue-chip OMXC25 index fell about 4.7% last week, the weakest showing in the Nasdaq Nordic region, after heavyweight Novo Nordisk slumped more than 16% on Monday following an obesity-drug trial setback. 1
That matters now because the Nordic tape is still concentrated. When a single large name moves hard, it can swamp what’s happening elsewhere — and the week ends with investors trying to work out whether the drag stays boxed in Denmark or leaks into broader risk appetite.
The timing is awkward. Markets reopen on Monday with traders already braced for another big macro catalyst — the U.S. jobs report due March 6 — and strategists warning that equity markets are still jittery about who wins and loses from fast-moving AI spending. “Trying to find the winners and losers,” is how BNY’s John Velis put it. 4
The pan-Nordic OMX Nordic 40 index — which tracks 40 of the largest and most actively traded stocks across the Nordic exchanges — finished Friday at 2,617.28, up 0.61% on the day but down about 2.2% for the week, Nasdaq data showed. 2
Sweden was the outlier on the upside. Stockholm’s OMXS30 ended at 3,222.75 on Friday, up 0.55% on the day and up about 1.3% on the week, while Finland’s OMXH25 closed at 6,147.52, up 0.93% on Friday and about 0.6% higher on the week. 5
In Stockholm, the rally leaned on tech and a handful of sharp single-stock moves late in the week. Technology led major industrial groups with a 2.5% gain in one session, while raw materials lagged; heat-pump maker Nibe and measurement software group Hexagon both jumped, and miner Boliden fell, according to a Finwire market report carried by MarketScreener. 6
Among company catalysts, Better Collective drew attention after publishing its annual financial report and laying out 2026 targets. Co-CEO Jesper Søgaard said the group ended 2025 with “our highest EBITDA ever,” and flagged investment in AI products as it moves into 2026; EBITDA is a cash-earnings measure used widely in Nordic reporting. 7
Elsewhere in Sweden, insider buying at EQT was on traders’ screens. Incoming chair Jean Eric Salata bought 500,000 shares for about 137.9 million crowns on Feb. 23, a disclosure in Sweden’s insider registry showed, according to a MarketScreener report. 8
The Nordic split came even as broader European equities held up. The STOXX 600 ended Friday at a record high and logged its eighth straight monthly rise, Reuters reported, a contrast to the Nordic benchmark’s weekly drop. 9
Global risk signals were messy into the close. U.S. stocks ended February with sharp monthly declines amid a mix of AI unease, tariff uncertainty and geopolitical worries; “we were reminded there are still some cracks out there,” Carson Group strategist Ryan Detrick said. 10
But the path isn’t one-way. If Novo Nordisk stabilises and bargain-hunting shows up in Danish healthcare, the region’s tone can change quickly. The flip side is that another negative headline in obesity drugs — or a fresh risk-off lurch from U.S. tech — could keep Denmark on the back foot and cap any rebound in the wider Nordic index.
What investors watch next is pinned to the calendar. The U.S. employment report is due on March 6, while the European Central Bank’s next monetary policy meeting runs March 18–19 and Sweden’s Riksbank publishes its March policy decision on March 19. 3
